Senhwa Biosciences, Inc. (6492.TWO)
TWD 42.5
(0.47%)
TWD 42.5
(0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -286.35 Million | -399.97 Million | -300.05 Million | -272.68 Million | -384.5 Million | -374.34 Million |
| Net Income | -296.3 Million | -349.63 Million | -329.25 Million | -354.87 Million | -391.42 Million | -375.85 Million |
| Depreciation & Amortization | 10.72 Million | 7.11 Million | 6.23 Million | 7.11 Million | 8.16 Million | 2.82 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | -641 Thousand | 1.02 Million | 3.46 Million | 51.45 Million | - | - |
| Change in working capital | 977 Thousand | -58.22 Million | 27.41 Million | 23.41 Million | -16.18 Million | -16.86 Million |
| Other non-cash items | 29.57 Million | 14.86 Million | 8.21 Million | 65.84 Million | 31.19 Million | 21.34 Million |
| Investing Cash Flow | -5.25 Million | -590 Thousand | 149 Thousand | -382 Thousand | 3000.00 | 186 Thousand |
| Investments in PPE | -4.77 Million | -369 Thousand | -401 Thousand | -391 Thousand | - | -406 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -482 Thousand | -221 Thousand | 550 Thousand | 9000.00 | 3000.00 | 592 Thousand |
| Financing Cash Flow | -8.82 Million | -19.55 Million | -34.24 Million | 1.8 Billion | -5.56 Million | 1 Million |
| Debt repayment | -8.82 Million | - | - | -9.63 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -13.23 Million | -36.12 Million | -1.98 Million | - | - |
| Common Stock Issuance | - | - | 6.8 Million | 1.8 Billion | 280 Thousand | 1 Million |
| Other Financing Activities | -8.82 Million | - | - | -1.98 Million | - | - |
| Accounts receivables | -9.87 Million | 138 Thousand | -190 Thousand | 49 Thousand | 73 Thousand | -151 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 10.85 Million | -58.36 Million | 27.6 Million | 23.36 Million | -16.25 Million | -16.71 Million |
| Cash at beginning of period | 1.61 Billion | 2.03 Billion | 2.36 Billion | 837.27 Million | 1.22 Billion | 1.6 Billion |
| Cash at end of period | 1.31 Billion | 1.61 Billion | 2.03 Billion | 2.36 Billion | 837.27 Million | 1.22 Billion |
| Capital Expenditure | -4.77 Million | -369 Thousand | -401 Thousand | -391 Thousand | - | -406 Thousand |
| Effect of forex changes on cash | 109 Thousand | 6.67 Million | -1.85 Million | -4.28 Million | - | - |
| Net cash flow / Change in cash | -300.32 Million | -413.44 Million | -335.99 Million | 1.53 Billion | -392.21 Million | -371.5 Million |
| Free Cash Flow | -291.12 Million | -400.34 Million | -300.45 Million | -273.07 Million | -384.5 Million | -374.74 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -69.65 Million | -63.14 Million | -296.3 Million | -83.59 Million | -75.14 Million | -64.42 Million |
| Depreciation & Amortization | 3.03 Million | 2.98 Million | 10.72 Million | 2.81 Million | 2.81 Million | 2.75 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | -641 Thousand | - | - | 42 Thousand |
| Change in working capital | -2.91 Million | -17.39 Million | 977 Thousand | 23.04 Million | 181 Thousand | -1.79 Million |
| Other non-cash items | 3.3 Million | 3.06 Million | 29.57 Million | 4.27 Million | 5.73 Million | 15.2 Million |
| Investing Cash Flow | 2.26 Million | 352 Thousand | -5.25 Million | 2000.00 | -10 Thousand | -225 Thousand |
| Investments in PPE | - | -1.95 Million | -4.77 Million | - | - | -169 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -720 Million | -780 Million | - | - | - | -800 Million |
| Sales/Maturities of investments | 722.26 Million | 782.32 Million | - | - | - | 802.12 Million |
| Other Investing Activities | -1000.00 | -15 Thousand | -482 Thousand | 2000.00 | -10 Thousand | -56 Thousand |
| Financing Cash Flow | -2.02 Million | -2.01 Million | -8.82 Million | -2.15 Million | -2.67 Million | -1.89 Million |
| Debt repayment | -2.02 Million | - | - | - | -341 Thousand | -341 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.02 Million | - | - | - | - | - |
| Accounts receivables | -91 Thousand | -346 Thousand | -9.87 Million | 867 Thousand | -400 Thousand | -10.12 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.82 Million | -17.04 Million | 10.85 Million | 22.17 Million | 581 Thousand | 8.32 Million |
| Cash at beginning of period | 1.23 Billion | 1.31 Billion | 1.61 Billion | 1.38 Billion | 1.45 Billion | 1.51 Billion |
| Cash at end of period | 1.16 Billion | 1.23 Billion | 1.31 Billion | 1.31 Billion | 1.38 Billion | 1.45 Billion |
| Capital Expenditure | - | -1.95 Million | -4.77 Million | - | - | -169 Thousand |
| Effect of forex changes on cash | 830 Thousand | 1.97 Million | 109 Thousand | -3.08 Million | 2.35 Million | 1.38 Million |
| Net cash flow / Change in cash | -71.31 Million | -80.49 Million | -300.32 Million | -63.46 Million | -72.76 Million | -64.6 Million |
| Free Cash Flow | -72.38 Million | -82.76 Million | -291.12 Million | -58.22 Million | -72.43 Million | -64.05 Million |
6719
6496
WJG
DLINKINDIA
3088
ABB